Specific therapeutic options for transthyretin amyloidosis
The epidemiology of systemic amyloidosis has recently undergone a spectacular transformation. While light-chain amyloidosis remains a rare disease with a stable incidence, chronic inflammatory disease associated amyloidosis (AA) is diagnosed less frequently, the incidence of the mutational and wild-...
| Autore principale: | |
|---|---|
| Natura: | Articolo |
| Lingua: | English |
| Pubblicazione: |
Promenade Kft
2024-12-01
|
| Serie: | Cardiologia Hungarica |
| Soggetti: | |
| Accesso online: | https://cardiologia.hungarica.eu/archive/2024-issues/2024-6-contents/specific-therapeutic-options-for-transthyretin-amyloidosis?article=open |